Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 38

Cited In for PubMed (Select 16369025)

1.

The cyclopentenone prostaglandin 15d-PGJ2 inhibits the NLRP1 and NLRP3 inflammasomes.

Maier NK, Leppla SH, Moayeri M.

J Immunol. 2015 Mar 15;194(6):2776-85. doi: 10.4049/jimmunol.1401611. Epub 2015 Feb 13.

PMID:
25681332
2.

A heterodimer of a VHH (variable domains of camelid heavy chain-only) antibody that inhibits anthrax toxin cell binding linked to a VHH antibody that blocks oligomer formation is highly protective in an anthrax spore challenge model.

Moayeri M, Leysath CE, Tremblay JM, Vrentas C, Crown D, Leppla SH, Shoemaker CB.

J Biol Chem. 2015 Mar 6;290(10):6584-95. doi: 10.1074/jbc.M114.627943. Epub 2015 Jan 6.

PMID:
25564615
3.

clpC operon regulates cell architecture and sporulation in Bacillus anthracis.

Singh LK, Dhasmana N, Sajid A, Kumar P, Bhaduri A, Bharadwaj M, Gandotra S, Kalia VC, Das TK, Goel AK, Pomerantsev AP, Misra R, Gerth U, Leppla SH, Singh Y.

Environ Microbiol. 2015 Mar;17(3):855-65. doi: 10.1111/1462-2920.12548. Epub 2014 Jul 17.

PMID:
24947607
4.

Identification of three noncontiguous regions on Bacillus anthracis plasmid pXO1 that are important for its maintenance.

Pomerantsev AP, Chang Z, Rappole C, Leppla SH.

J Bacteriol. 2014 Aug 15;196(16):2921-33. doi: 10.1128/JB.01747-14. Epub 2014 Jun 9.

5.

The Bacillus cereus Hbl and Nhe tripartite enterotoxin components assemble sequentially on the surface of target cells and are not interchangeable.

Sastalla I, Fattah R, Coppage N, Nandy P, Crown D, Pomerantsev AP, Leppla SH.

PLoS One. 2013 Oct 18;8(10):e76955. doi: 10.1371/journal.pone.0076955. eCollection 2013.

6.

Rapid targeted gene disruption in Bacillus anthracis.

Saldanha RJ, Pemberton A, Shiflett P, Perutka J, Whitt JT, Ellington A, Lambowitz AM, Kramer R, Taylor D, Lamkin TJ.

BMC Biotechnol. 2013 Sep 18;13:72. doi: 10.1186/1472-6750-13-72.

7.

Generalized bacterial genome editing using mobile group II introns and Cre-lox.

Enyeart PJ, Chirieleison SM, Dao MN, Perutka J, Quandt EM, Yao J, Whitt JT, Keatinge-Clay AT, Lambowitz AM, Ellington AD.

Mol Syst Biol. 2013;9:685. doi: 10.1038/msb.2013.41.

8.

Key tissue targets responsible for anthrax-toxin-induced lethality.

Liu S, Zhang Y, Moayeri M, Liu J, Crown D, Fattah RJ, Wein AN, Yu ZX, Finkel T, Leppla SH.

Nature. 2013 Sep 5;501(7465):63-8. doi: 10.1038/nature12510. Epub 2013 Aug 28.

9.

Small-molecule inhibitors of lethal factor protease activity protect against anthrax infection.

Moayeri M, Crown D, Jiao GS, Kim S, Johnson A, Leysath C, Leppla SH.

Antimicrob Agents Chemother. 2013 Sep;57(9):4139-45. doi: 10.1128/AAC.00941-13. Epub 2013 Jun 17.

10.

CtsR regulation in mcsAB-deficient Gram-positive bacteria.

Tao L, Chattoraj P, Biswas I.

J Bacteriol. 2012 Mar;194(6):1361-8. doi: 10.1128/JB.06746-11. Epub 2012 Jan 13.

11.

Methylation-dependent DNA restriction in Bacillus anthracis.

Sitaraman R, Leppla SH.

Gene. 2012 Feb 15;494(1):44-50. doi: 10.1016/j.gene.2011.11.061. Epub 2011 Dec 8.

12.

Occurrence, recognition, and reversion of spontaneous, sporulation-deficient Bacillus anthracis mutants that arise during laboratory culture.

Sastalla I, Leppla SH.

Microbes Infect. 2012 May;14(5):387-91. doi: 10.1016/j.micinf.2011.11.009. Epub 2011 Nov 28. Review.

13.

Lipoprotein biosynthesis by prolipoprotein diacylglyceryl transferase is required for efficient spore germination and full virulence of Bacillus anthracis.

Okugawa S, Moayeri M, Pomerantsev AP, Sastalla I, Crown D, Gupta PK, Leppla SH.

Mol Microbiol. 2012 Jan;83(1):96-109. doi: 10.1111/j.1365-2958.2011.07915.x. Epub 2011 Nov 22.

14.

Cloning-independent and counterselectable markerless mutagenesis system in Streptococcus mutans.

Xie Z, Okinaga T, Qi F, Zhang Z, Merritt J.

Appl Environ Microbiol. 2011 Nov;77(22):8025-33. doi: 10.1128/AEM.06362-11. Epub 2011 Sep 23.

15.

Mouse monoclonal antibodies to anthrax edema factor protect against infection.

Leysath CE, Chen KH, Moayeri M, Crown D, Fattah R, Chen Z, Das SR, Purcell RH, Leppla SH.

Infect Immun. 2011 Nov;79(11):4609-16. doi: 10.1128/IAI.05314-11. Epub 2011 Sep 12.

16.

The Bacillus subtilis extracytoplasmic function σ factor σ(V) is induced by lysozyme and provides resistance to lysozyme.

Ho TD, Hastie JL, Intile PJ, Ellermeier CD.

J Bacteriol. 2011 Nov;193(22):6215-22. doi: 10.1128/JB.05467-11. Epub 2011 Aug 19.

17.

A Bacillus anthracis strain deleted for six proteases serves as an effective host for production of recombinant proteins.

Pomerantsev AP, Pomerantseva OM, Moayeri M, Fattah R, Tallant C, Leppla SH.

Protein Expr Purif. 2011 Nov;80(1):80-90. doi: 10.1016/j.pep.2011.05.016. Epub 2011 Aug 7.

18.
19.

Regulon of the N-acetylglucosamine utilization regulator NagR in Bacillus subtilis.

Bertram R, Rigali S, Wood N, Lulko AT, Kuipers OP, Titgemeyer F.

J Bacteriol. 2011 Jul;193(14):3525-36. doi: 10.1128/JB.00264-11. Epub 2011 May 20.

20.

Delayed treatment with W1-mAb, a chimpanzee-derived monoclonal antibody against protective antigen, reduces mortality from challenges with anthrax edema or lethal toxin in rats and with anthrax spores in mice.

Altaweel L, Chen Z, Moayeri M, Cui X, Li Y, Su J, Fitz Y, Johnson S, Leppla SH, Purcell R, Eichacker PQ.

Crit Care Med. 2011 Jun;39(6):1439-47. doi: 10.1097/CCM.0b013e3182120691.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk